Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-03-11 08:19 am Sale | 13G | IKENA ONCOLOGY INC IKNA | FMR LLC | 1,215,002 2.771% | -2,969,291 (-70.96%) | View |
| 2024-02-14 4:57 pm Sale | 13G | IKENA ONCOLOGY INC IKNA | CITADEL ADVISORS LLC | 178,177 0.4% | -1,976,957 (-91.73%) | View |
| 2024-02-14 4:48 pm Unchanged | 13G | IKENA ONCOLOGY INC IKNA | Omega Fund VI L.P. | 2,249,123 4.7% | 0 (Unchanged) | View |
| 2024-02-14 09:47 am Purchase | 13G | IKENA ONCOLOGY INC IKNA | BIOTECHNOLOGY VALUE FUND L P | 4,769,164 9.9% | 2,266,093 (+90.53%) | View |
| 2024-02-09 09:16 am Purchase | 13G | IKENA ONCOLOGY INC IKNA | FMR LLC | 4,184,293 9.545% | 459,718 (+12.34%) | View |
| 2023-10-19 3:33 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | GILEAD SCIENCES INC. GILD | 2,931,467 6.7% | 2,931,467 (New Position) | View |
| 2023-09-21 4:52 pm Sale | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 2,189,111 5.2% | -153,121 (-6.54%) | View |
| 2023-09-14 4:21 pm Purchase | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 2,342,232 5.5% | 405,346 (+20.93%) | View |
| 2023-02-14 08:02 am Purchase | 13G | IKENA ONCOLOGY INC IKNA | CITADEL ADVISORS LLC | 2,155,134 5.9% | 26,926 (+1.27%) | View |
| 2023-02-13 6:11 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | BIOTECHNOLOGY VALUE FUND L P | 2,503,071 6.9% | 704,700 (+39.19%) | View |
| 2023-01-10 12:48 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | FMR LLC | 3,724,575 10.272% | 1,198,372 (+47.44%) | View |
| 2022-10-11 09:03 am Sale | 13G | IKENA ONCOLOGY INC IKNA | FMR LLC | 2,526,203 6.967% | -2,197,484 (-46.52%) | View |
| 2022-02-14 2:57 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | Omega Fund VI L.P. | 2,249,123 6.3% | 2,249,123 (New Position) | View |
| 2022-02-14 1:35 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | BIOTECHNOLOGY VALUE FUND L P | 1,798,371 5% | 198,713 (+12.42%) | View |
| 2022-02-14 06:12 am Purchase | 13G | IKENA ONCOLOGY INC IKNA | CITADEL ADVISORS LLC | 2,128,208 5.9% | 73,255 (+3.56%) | View |
| 2022-02-11 5:12 pm Purchase | 13D | IKENA ONCOLOGY INC IKNA | Atlas Venture Fund X L.P. | 2,901,609 8.1% | 2,901,609 (New Position) | View |
| 2022-02-09 09:19 am Purchase | 13G | IKENA ONCOLOGY INC IKNA | FMR LLC | 4,723,687 13.155% | 946,049 (+25.04%) | View |
| 2021-08-16 4:45 pm Unchanged | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 1,936,886 5.4% | 0 (Unchanged) | View |
| 2021-04-14 7:31 pm Purchase | 13D | IKENA ONCOLOGY INC IKNA | ORBIMED ADVISORS LLC | 1,936,886 6.56% | 1,936,886 (New Position) | View |
| 2021-04-12 1:05 pm Purchase | 13G | IKENA ONCOLOGY INC IKNA | FMR LLC | 3,777,638 12.541% | 3,777,638 (New Position) | View |